Maravai LifeSciences第一季度平均每股收益$（0.08）低于$（0.07）估计，销售额为4，685万美元，超过4，401万美元估计

Maravai LifeSciences (NASDAQ: MRVI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 300 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $46.85 million which beat the analyst consensus estimate of $44.01 million by 6.46 percent. This is a 27.00 percent decrease over sales of $64.18 million the same period last year.